Background-The ability to image incipient atherosclerosis is based on the early events taking place at the endothelial level. We hypothesized that the expression of intercellular adhesion molecule-1 even in vessels with high flow rates can be imaged at the molecular level using 2 complementary imaging techniques: 2-photon laser scanning microscopy and contrast-enhanced ultrasound. Methods and Results-Using 2-photon laser scanning microscopy and contrast-enhanced ultrasound, intercellular adhesion molecule-1-targeted and rhodamine-loaded microbubbles were shown to be specifically bound to tumor necrosis factor-α-stimulated human umbilical vein endothelial cells and murine carotid arteries (44 wild-type mice) at shear stresses ranging from 1.25 to 120 dyn/cm 2 . Intercellular adhesion molecule-1-targeted and rhodamine-loaded microbubbles bound 8× more efficient (P=0.016) to stimulated human umbilical vein endothelial cells than to unstimulated cells and 14× more than nontargeted microbubbles (P=0.016). In excised carotids, binding efficiency did not decrease significantly when increasing the flow rate from 0.25 to 0.6 mL/min. Higher flow rates (0.8 and 1 mL/min) showed significantly reduced microbubbles retention, by 38% (P=0.03) and 55% (P=0.03), respectively. Ex vivo results were translatable in vivo, confirming that intercellular adhesion molecule-1-targeted and rhodamine-loaded microbubbles are able to bind specifically to the inflamed carotid artery endothelia under physiological flow conditions and to be noninvasively detected using contrast-enhanced ultrasound. Conclusions-Our data provide groundwork for the implementation of molecular ultrasound imaging in vessels with high shear stress and flow rates, as well as for the future development of image-guided therapeutic interventions, and multiphoton microscopy as the appropriate method of validation. (Circ Cardiovasc Imaging. 2013;6:974-981.)
A therosclerosis, a chronic inflammatory disorder developing in arterial vessels, 1,2 is caused mainly by alterations in arterial shear stress, 3 followed by subendothelial accumulation of lipids and inflammatory cells leading to wall thickening and segmental lumen narrowing. The detection of atherosclerosis using imaging modalities, such as computed tomography, MRI, and ultrasound, is challenging and in many cases only possible in the late stages of disease progression, when the plaque narrows the arterial lumen and determines clinical manifestations. 4 The main challenge is to diagnose and ultimately to intervene therapeutically in the atherosclerotic process during the early stages of disease progression.
Clinical Perspective on p 981
The endothelium does play a prominent role not only in the early stage of atherosclerosis, but also after conventional balloon angioplasty. Abnormal shear stress and the aggressive fat accumulation in the vessel wall are followed by strong endothelial activation. Activated endothelial cells upregulate surface adhesion molecules, such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 (ICAM-1) that can initiate leukocyte recruitment and transmigration, thereby contributing to the plaque growth. [5] [6] [7] These distinct adhesion molecules can be used for molecular imaging purposes. In this context, because of the fact that these are intravascular markers, ultrasound molecular imaging with target-specific micrometer-sized gas bubbles (which stay strictly intravascular) present a suitable method for the imaging of endothelial dysfunction. However, molecular imaging of activated endothelium in major vessels, such as carotid arteries, is a daunting task because of the high flow and shear rates. Therefore, ultrasound molecular imaging studies on atherosclerosis have tried to overcome these obstacles by various methods, including modulating the microbubble surface coverage with ligands, 8 using multiple targeting ligands, 9 etc, mostly in vitro on cell cultures. So far, in vivo binding assessment of targeted microbubbles has been limited to the aortic arch, 10 which characteristically has a larger diameter (≤3-fold) and significantly lower shear stress than carotid arteries. 11 The aim of this investigation is to show that contrast-enhanced ultrasound (CEUS) using targeted microbubbles can be applied for molecular imaging of carotid incipient atherosclerosis at physiological flow and shear rates. Polymeric microbubbles have been shown to be suitable contrast agents for functional and molecular ultrasound imaging. 12 The target of choice was ICAM-1 because of its physiological relevance in the early stages of plaque development, 13 but also because of its tumor necrosis factor-α (TNFα)-dependent upregulation.
14 Using ICAM-1-targeted and rhodamine-labeled microbubbles, 15 the binding of microbubbles to inflamed endothelial surfaces was investigated systematically under different flow and shear-stress conditions, visualized by CEUS, and quantitatively validated by 2-photon laser scanning microscopy (TPLSM). These results serve as a proof of concept that CEUS with targeted microbubbles can be performed in carotid arteries and stress the appropriateness of TPLSM as validation method in tissues.
Methods

Synthesis of Rhodamine-Loaded Target-Specific Microbubbles
Rhodamine-encapsulated poly(n-butyl cyanoacrylate) (PBCA) microbubbles were synthesized as previously described. 12 In brief, 3 mL of monomeric butyl-2-cyanoacrylate (Special Polymer Ltd) was added drop wise to 300 mL of an aqueous solution of 1% Triton X-100 (Sigma-Aldrich) at pH 2.5. Subsequently, rhodamine-B was dissolved in 300 μL of distilled water and added to the mixture. Using an Ultra Turrax, the mixture was then stirred for 60 minutes at 10 000 rpm. The resulting rhodamine-loaded microbubble suspension was washed several times by flotation to remove the excess rhodamine.
For the conjugation of streptavidin (Applichem) to the microbubble surface, the ester groups were partially hydrolyzed. Subsequently, streptavidin was conjugated to the microbubbles by a 1-ethyl-3-(3-dimethylaminopropyl)carbidiimide hydrochloride (Sigma-Aldrich) reaction between the amine group of the streptavidin and the carboxylic group of the microbubble surface, followed by 3 flotation steps. Size distribution and microbubble concentration were determined with the particle counter Multisizer 3 (Beckman-Coulter; Figure I in the online-only Data Supplement).
Antibody Labeling
A total of 1×10 7 streptavidin-coated microbubbles in HEPES/Triton buffer (pH 7.0) were mixed with 5 µg of biotinylated ICAM-1 antibodies and incubated at room temperature for 30 minutes. The conjugated microbubbles were separated from excess antibodies by centrifugation (500 rpm for 2 minutes) and resuspended in 100-µL HEPES/Triton buffer.
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were grown and maintained in endothelial cell growth medium II, supplemented with 10% (v/v) heat inactivated fetal bovine serum, endothelial cell growth supplement, and 1% (v/v) gentamicin at 37°C in a 5% CO 2 humidified atmosphere. All reagents were purchased from Promocell.
In Vitro Flow Chamber
A total of 100 µL of HUVECs were seeded (1×10 6 cells/mL) on collagen-coated 35-mm Petri dishes. The cells were incubated with 40 ng of recombinant human TNFα (PeproTech) for 4 hours before microbubble perfusion. The cells were incubated with WGA-AF488 (1:1000) and SYTO 41 (1:1000; Invitrogen) for 45 minutes and then washed with 1× PBS. The Petri 35-mm dishes were mounted into a customized parallel-wall flow chamber in a custom silicon tube closed perfusion system (standard silicon tubing, 0.76 mm inner diameter; Helixmark). Using a peristaltic pump (Gilson Inc), a continuous flow rate of 0.25 mL/min was set. A total of 1×10 7 ICAM-conjugated microbubbles were injected into the perfusion system, and a closed loop circulation was performed for 10 minutes, followed by a 10-minute washing step using 1× PBS with an open loop. Fluorescence images were obtained subsequently using a Axio Imager M2 fluorescence microscope (Carl Zeiss AG, Germany).
Immunohistology
For immunohistology, perfusion fixation with 4% paraformaldehyde (P-6148, Sigma) and paraffin embedding, either PBS perfusion followed by Tissue-Tek O.C.T. (4583, Sakura) embedding and snapfreezing was performed. Serial tissue sections (5 μm) starting with the bifurcation were obtained from isolated carotids and stained for ICAM-1 (Santa Cruz Biotechnology Inc, sc-52553), vascular cell adhesion molecule-1 (16-1061, eBioscience), P-selectin (sc-6941), E-selectin (sc-6939), and CD31 (sc-1506) expression. Biotinylated secondary antibodies (anti-rat IgG BA-4000 and anti-goat IgG BA-5000, Vector Laboratories) followed by fluorescein streptavidin (SA-5001, Vector Laboratories) conjugation were used for specific staining visualization, and sections were analyzed using Diskus software (Hilgers).
Murine Model of Endothelial Activation
All animal experiments were approved by local authorities and complied with German animal protection law. Endothelial activation was induced in 8-week-old male CD-1 wild-type mice via intraperitoneal injection of recombinant murine TNFα (PeproTech) 0.067 mg/kg. Control mice and TNFα-stimulated mice were euthanized by intraperitoneal injection of anesthetic overdose (400 mg/kg ketamine and 40 mg/kg xylazine) 4 hours after TNFα injection, and both (left and right) common carotids excised by a cervico-thoracic incision. 
Ex vivo Perfusion
Mice were euthanized by intraperitoneal overdose injection of anesthetic. The common carotid arteries (6-7 mm) were excised and freed from adipose and connective tissue, without damaging the blood vessel. Handling of the blood vessel was restricted only to both ends. To avoid air bubbles within the lumen, the blood vessels were preserved at 4°C in 1× Hanks' Balanced Salt Solution (HBSS, pH 7.4, Life technology) before the mounting procedure. Each excited carotid was mounted in a customized flow chamber, filled with HBSS (37°C). 16 The carotid was mounted on each side onto glass pipettes (tip diameter, 120-150 μm). Luminal blood residues were removed by flushing with 1× HBSS. To correct for shortening and deflation of the carotid, the blood vessel was pressurized (60 mm Hg) and stretched. Fresh blood collected from healthy volunteers was anticoagulated with heparin (10 U/mL)-EDTA (1.2-2 mg EDTA/mL) and infused through the carotids at a flow rate of 0.25 mL/min for 2 minutes.
All flow experiments were conducted at 37°C using flow rates ranging from 0.25 to 1 mL/min (0.25, 0.6, 0.8, and 1 mL/min) in a custom silicon tube perfusion system using standard silicon tubing (0.76 mm inner diameter, Helixmark), and flow was established using a peristaltic pump in the same direction as under physiological conditions. Either targeted or control microbubbles (107/mL), suspended in whole blood, were infused for 10 minutes, followed by 10-minute washing using human blood (ex vivo ultrasound investigations were performed without removing the circulating microbubbles). For competitive binding studies, the TNFα-stimulated carotid was perfused with 20-fold higher concentration of free ICAM antibody (100 μg; 2 μg/μL) for 10 minutes before microbubble injection. The carotid was then imaged using CEUS or TPLSM. The number of animals used for this study is n=20.
Ex Vivo Ultrasound Imaging
Tissue preparation was performed as described. High-resolution imaging of the carotid arteries was performed with a high-frequency (21 MHz) imaging system (Vevo 2100, VisualSonics Inc) using a longaxis imaging plane. Imaging was performed as described in Kiessling et al. 17 We considered that after 10 minutes of continuous flow, microbubble distribution is homogeneous in the circulating blood, and imaging can be performed. The cumulative signal of circulating and bound microbubbles can be detected in the imaging frames before the destructive pulse. Microbubble-specific signal was distinguished by nonlinear contrast-mode data acquisition. An imaging sequence of 100 seconds (10 frames/second) was acquired with low-power imaging (4%), followed by a short increase of the acoustic amplitude to 100% power at the end of the first third of the imaging sequence to destroy the microbubbles in the field of view. The early replenishment of signal intensity represents the renewed inflow and binding of microbubbles. Microbubble-derived contrast enhancement does not reach predestruction levels because of reduced availability of binding sites. The destruction of bound microbubbles does not release the receptor but keeps it occupied with the antibody bound to the microbubble residue. Image analysis was performed by subtracting the mean contrast power for predestructive frames (bound+circulating microbubbles) from the postdestructive frames (only circulating microbubbles). The mean contrast decrease represents the amount of signal generated by retained microbubbles. The number of animals used for this studies is n=8.
In Vivo Ultrasound Imaging
Mice were stimulated with TNFα, according to our murine model of endothelial activation. In vivo molecular ultrasound measurements were performed using a small animal high-frequency ultrasound system (Vevo 770) and a 45-MHz transducer. Seven minutes after injection of 100 μL of ICAM-1-targeted microbubbles (MB ICAM-1 ; 2×10 7 ) into the tail vein, ultrasound imaging in contrast-mode was performed analogously to the ex vivo flow chamber experiments. The number of animals used for this study is n=10.
Two-Photon Laser Scanning Microscopy
The carotid artery within the flow chamber was imaged using an Olympus FV1000MPE multiphoton microscopy system (Mai Tai DeepSee pulsed Ti:Sapphire laser with 140 fps pulse width at an excitation wavelength of 800 nm and a 25× water dipping objective (NA [numerical apertures]=1.05, WD [working distance]=2 mm). Three internal photon multiplier tubes were used to detect the fluorescence signals, and filters were adjusted to the corresponding spectra: 390 to 460 for collagen second harmonic imaging, 490 to 540 for elastin autofluorescence, and 590 to 620 for rhodamine. TPLSM images were analyzed using Image-Pro Analyzer 7.0 software (Media Cybernetis, Inc) and Imaris software (Bitplane).
Vessel Diameter Estimation and Shear-Stress Calculation
Vessel diameter estimation was performed as described in van Triest et al. 18 Accordingly, shear stress for each carotid was calculated based on the Haagen-Poiseuille equation. Blood viscosity at 37°C was estimated at 0.004 Pa×s.
Statistical Analysis
Microbubble adhesion efficiency both in vitro, ex vivo, and in vivo (n=5) was analyzed using the Mann-Whitney test, and P<0.05 is considered significant. Error bars shown on graphs are the SE of the mean. To correct for multiple group comparison, we performed the Bonferroni correction. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software).
Results
Analysis of Biomarker Expression After Carotid Artery Stimulation
To characterize the molecular expression of endothelial surface receptors after TNFα stimulation and to determine the most suitable targeting ligand for the microbubbles binding studies, immunostainings on TNFα-stimulated carotids from wild-type mice were performed, showing ICAM-1, P-selectin, E-selectin, and CD31 expression on the luminal surface of activated endothelial cells (Figure 1 Figure II in the online-only Data Supplement). In addition, TNFα significantly increased P-selectin and CD31 expression on the endothelial cells' surface. However, ICAM-1 seemed to be the most densely expressed target out of the 5. For this reason, we have chosen ICAM-1 instead of the other surface adhesion ligands to conduct in vitro and ex vivo binding studies.
Analysis of the Binding Capacity of MB ICAM-1 In Vitro
Corresponding in vitro cell stainings of TNFα-stimulated HUVECs also showed a significant increase of ICAM-1 expression (Figure 2A number of bound microbubbles was determined using fluorescence microscopy, showing that MB ICAM-1 bound 8× more (P=0.0158) to stimulated HUVECs than to unstimulated cells ( Figure 2B and 2E) and 14× more than nontargeted microbubbles (P=0.0158). There was no significant difference between the binding efficiency of nontargeted microbubbles ( Figure 2C ) and targeted microbubbles on nonstimulated HUVECs, showing the binding specificity of the MB ICAM-1 under shear stress. To confirm microbubble binding, z-stacked images were recorded using TPLSM and reconstructed using Image-Pro Analyzer. Image analysis confirmed that the microbubbles were bound to the cellular surface and not floating on top of the cells ( Figure 2D ).
TPLSM Analysis of MB ICAM-1 Binding in the Ex Vivo Carotid Flow Chamber Assay
To test the microbubbles in a more physiological setup, we performed further binding assays in excised inflamed murine carotid arteries ( Figure 3A and 3B). Wild-type mice were intraperitonially injected with 1-µg TNFα and stimulated for 4 hours before tissue excision. We initially performed binding studies in HBSS, which showed significant unspecific binding of untargeted control microbubbles ( Figure III in the online-only Data Supplement). The untargeted microbubbles showed an 80% retention after a 10-minute washing step and 70% after a second washing step. When switching the flow medium to human whole blood, unspecific binding was reduced drastically, to ≈10% after 2 washing steps ( Figure III in the online-only Data Supplement).
The ex vivo data confirmed our finding of the in vitro binding studies, showing that at a low flow rate of 0.25 mL/min (P=0.0304), MB ICAM-1 bound 7.5× more to TNFα-stimulated endothelium than to unstimulated endothelium. Furthermore, unspecific binding of untargeted microbubbles was marginal, indicating ICAM-mediated binding of the microbubbles. This was further confirmed by competition experiments with free ICAM-1 antibodies.
In addition, microbubble accumulation was assessed at 3 higher flow rates: 0.6, 0.8, and 1 mL/min. Although at a flow rate of 0.6 mL/min, binding efficiency did not significantly decrease compared with 0.25 mL/min (P=0.42), higher flow rates, that is, 0.8 and 1 mL/min, showed significantly reduced microbubbles retention, by 38% (P=0.0304) and 55% (P=0.0304), respectively ( Figure 3C ).
As shear stress is strongly dependent on flow rate and vessel diameter, 19 an accurate determination of vessel diameter combined with a fixed flow rate provides the corresponding shear stress for each individual carotid, accounting for variability. For an accurate determination of shear stress in each carotid, the vessel diameters were measured based on the curvature of the blood vessel ( Figure 3D) . 18 The microbubble accumulation is high at low shear stress (10-50 dyn/cm 2 ) and decreases with increasing shear stress.
Ultrasound Analysis of MB ICAM-1 Binding in the Ex Vivo Carotid Artery Assay
We then investigated the binding efficiency of MB ICAM-1 in explanted carotids mounted in flow chambers using CEUS. The gradual replacement of HBSS by blood ( Figure 4A and 4D) could be followed in B-mode when blood cells were detected entering the field of view. When HBSS was totally replaced by blood at 37°C under pulsatile injection, physiological experimental conditions were present. During continuous microbubble injection, an increase in specific signals was clearly observed in the imaging sequence of ultrasound contrast agent injection ( Figure 4B and 4D) compared with unspecific signals detected for plain blood injection ( Figure 4A ). In the imaging sequence with the destructive pulse ( Figure 4C ), cumulative signals from bound microbubbles together with the free-circulating ones were detected before the destruction pulse, and immediately after the destructive event only the free-circulating ones could be identified. Slow replenishment of the blood by re-entering microbubbles was seen in the same sequence. Statistical analysis of the MB ICAM-1 binding ( Figure 4E ) revealed a 2.5-fold higher signal decrease after microbubble destruction (P=0.0158) in TNFα-stimulated carotids compared with the unstimulated group and a 6-fold increase (P=0.0158) compared with untargeted microbubbles.
In Vivo Ultrasound Analysis of MB ICAM-1 Binding
Finally, we investigated the potential of MB ICAM-1 in vivo. Similar to the ex vivo flow chamber experiments, an increase in gray scale intensity was observed during microbubble injection, followed by microbubble blood-pool distribution and subsequent clearance. Although specific retention of microbubbles was clearly visible 7 minutes after MB ICAM-1 injection, no circulating microbubbles and thus also no replenishment at this late time point could be observed ( Figure 5 ). In this context, a 2.6-fold higher microbubble retention in TNFα-stimulated carotids was found compared with unstimulated ones (P=0.0079; Figure 5C ).
Discussion
In this report, we provide proof of principle for the complementary use of CEUS and 2-photon laser scanning microscopy showing quantitative analysis of microbubble binding kinetics to TNFα-stimulated HUVECs in vitro, to freshly excised murine carotid arteries ex vivo and noninvasive detection in vivo.
The upregulation of ICAM-1 in response to proinflammatory stimulation has been described in previous studies in the context of atherosclerosis and is considered a primary target for in vitro and in vivo molecular imaging. [20] [21] [22] We identify in the present study ICAM-1 as a viable marker for early inflammation in the carotid artery with high shear stress.
The combination of TPLSM and CEUS offers a unique perspective on the microbubble binding. The deep-tissue submicron resolution of TPLSM offers the possibility to visualize single microbubbles and consequently quantify the total number of microbubbles bound to the endothelial surface in the field of view, whereas noninvasive CEUS imaging covers the aspect of potential clinical application. Our data show that TPLSM quantification is in good agreement with CEUS. Both modalities were able to detect specifically bound microbubbles on inflamed endothelium. However, a discrepancy in the factor of signal amplification after microbubble binding PBCA microbubbles are hard-shelled microbubbles, which are known to scatter more but oscillate less than soft-shelled microbubbles during ultrasound imaging; therefore, not all bound microbubbles may be detected nonlinearly using the bubble-specific/contrast mode. 23 Using B-mode, reflection and scattering are the predominant signal sources. However, both PBCA microbubbles and blood cells are scatterers, whereas vessel walls account for reflections. This, therefore, results in background signals that can mask part of the scattering produced by the microbubbles in B-mode. 24 A direct correlation between the number of bound microbubbles and gray scale increase was not established because TPLSM and CEUS were applied on separate carotids. Although such kind of a comparison would be highly interesting, it would require different levels of ICAM-1 expression in the carotid, which goes beyond the scope of this article and is subject to a separate future study.
One of the key challenges of molecular imaging in major blood vessels is the retention of the contrast agent under high shear and flow rates. Nanosized contrast agents promote internalization and extravasation into the tissue, 25 protecting them from the shear forces in the lumen. However, this effect also increases unspecific uptake, making the differentiation between markerspecific and unspecific binding challenging. Microbubbles with an average size of 2 μm and a hard shell lack the flexibility of monocytes, thus they cannot extravasate and remain strictly in the vascular compartment, which makes these particles ideal endothelial contrast agents. Nevertheless, microbubble size and rigidness make them more prone to collisions with blood components and breaking; therefore, blood flow and shear stress play a limiting factor in the retention rate of these particles.
The shear stress within blood vessels is determined by many factors, such as vessel diameter, flow rate, blood viscosity, and vessel architecture. 19 Furthermore, shear stress is not constant throughout the entire vessel. 26 Not suprisingly, shear stresses found in the literature for murine carotids range between 28 and 142 dyn/cm 2 . 27 However, the predominant part of previous studies determines the shear stress within murine carotid to be in the range of 36 to 81 dyn/cm 2 at average flow rates between 0.35 and 0.75 mL/min. [28] [29] [30] [31] [32] In this study, we show in vitro and ex vivo that at low flow rate and shear stress at 0.25 mL/min (1.25 dyn/cm 2 in vitro and 20 dyn/cm 2 ex vivo), the binding of MB ICAM-1 is specific to inflamed endothelium. More importantly, with increasing flow and shear stress, our data show that even at physiological shear stress conditions of 35 to 60 dyn/cm 2 , 31,33 microbubble binding is not significantly reduced. Also, our data are in line with other publications showing that at higher shear stresses, microbubble retention and the rate of microbubble binding 34, 35 can be reduced both of which explain the gradual decrease of microbubble accumulation in excised carotid arteries at >60 dyn/cm 2 shear stresses. Our in vivo data are in good agreement with the ex vivo results, confirming that ICAM-1-targeted microbubbles are able to bind to the inflamed vascular wall under physiological flow conditions in the carotid artery, providing comparable contrast enhancement.
Ideally, CEUS would be the clinically preferred diagnostic tool for vascular imaging because of its noninvasive proprieties, beside availability, rapidity, lack of ionizing irradiation, and cost-efficiency. 36 Polymer-based microbubbles have many features that are beneficial for in vivo targeting. 37 Because of their size, they remain strictly in the vascular compartment and target primarily the endothelium. Therefore, microbubbles are highly suitable for molecular imaging of angiogenic and inflamed endothelial surfaces. 38 CEUS was used successfully in preclinical trials for tumor imaging [39] [40] [41] and thrombus characterization. 42 Moreover, anti-vascular cell adhesion molecule-1 antibody-coated microbubbles could localize successfully to atherosclerotic plaques in the aortic arch. 10 The main clinical application of ultrasound is in the field of stroke imaging. Therefore, ultrasound of the carotid artery is more clinically relevant. Furthermore, the flow and shear stress in carotid arteries are 2 to 3× higher than in the aortic arch, which makes our results translatable also to the relative low flow areas, such as the aortic arch. We identify in the present study ICAM-1 as a viable marker for the early inflammation in the carotid artery, which presents a significant higher shear flow. Furthermore, as reviewed by Cheng et al, 33 the shear stress in carotids is inversely related to the body weight and decreases from mice to humans by the factor of 6, ranging between 9.5 and 12.4 dyn/cm 2 . We have shown that the microbubbles used in this study can tolerate physiological and even much higher shear stresses in mice and, therefore, offer the potential for visualization of early inflammation in major blood vessel in human.
Conclusions
In this study, we have shown that CEUS using targeted microbubbles is a valuable method to be applied for molecular imaging of carotid incipient atherosclerosis at physiological and higher shear rates. We validated and correlated the results using TPLSM, optimizing a bimodal platform for molecular imaging of rhodamine-loaded microbubbles, which is crucial for the understanding of the basic mechanisms of atherosclerosis and for the development of new strategies to reduce vessel injury and promote tissue repair, reducing the risk of life-threatening complications such as heart infarction or stroke. 
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